tacrolimus
Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
Cross Reference
Introduction
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with tacrolimus?
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (2)
- Am. J. Physiol. Renal Physiol. (1)
- Drug Metab. Dispos. (1)
- Others (1)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with tacrolimus
PubChem Associated disorders and diseases
What pathways are associated with tacrolimus
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with tacrolimus?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with tacrolimus?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with tacrolimus?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with tacrolimus?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with tacrolimus?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with tacrolimus
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Allen BR et al. | Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients. | 2003 | Arch. Dis. Child. | pmid:14612358 |
| Hofman T et al. | Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children. | 2006 | Arch. Dis. Child. | pmid:16798785 |
| Nishimuta K and Ito Y | Effects of metronidazole and tinidazole ointments on models for inflammatory dermatitis in mice. | 2003 | Arch. Dermatol. Res. | pmid:12624780 |
| Ito F et al. | FK506 and cyclosporin A inhibit stem cell factor-dependent cell proliferation/survival, while inducing upregulation of c-kit expression in cells of the mast cell line MC/9. | 1999 | Arch. Dermatol. Res. | pmid:10367710 |
| Lubaki LJ et al. | Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus. | 2010 | Arch. Dermatol. Res. | pmid:19547993 |
| Eberlein-König B et al. | Modulation of histamine release in vitro by FK506 and interleukin-3 is determined by sequence of incubation. | 1997 | Arch. Dermatol. Res. | pmid:9373722 |
| Hultsch T et al. | Direct evidence that FK506 inhibition of FcepsilonRI-mediated exocytosis from RBL mast cells involves calcineurin. | 1998 | Arch. Dermatol. Res. | pmid:9681677 |
| GarcÃa-GarcÃa B et al. | Frosch' surface microscopy score for the assessment of steroid-induced atrophy. | 2014 | Arch. Dermatol. Res. | pmid:24402286 |
| Paus R et al. | Hair growth control by immunosuppression. | 1996 | Arch. Dermatol. Res. | pmid:8818191 |
| Furukawa F et al. | FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice. | 1995 | Arch. Dermatol. Res. | pmid:7487142 |
| Ockenfels HM et al. | Cyclosporin A, FK506 and dithranol after tyrosine-specific protein phosphorylation in HaCaT keratinocytes. | 1995 | Arch. Dermatol. Res. | pmid:7541191 |
| Yoon NY et al. | Topical glucocorticoid or pimecrolimus treatment suppresses thymic stromal lymphopoietin-related allergic inflammatory mechanism in an oxazolone-induced atopic dermatitis murine model. | 2015 | Arch. Dermatol. Res. | pmid:25786383 |
| Hofmann M et al. | Validation of Dermaphot(®) for the assessment of steroid-induced skin atrophy. | 2013 | Arch. Dermatol. Res. | pmid:23242470 |
| Toyota N et al. | Effects of FK506 and cyclosporin A on proliferation, histamine release and phenotype of murine mast cells. | 1996 | Arch. Dermatol. Res. | pmid:8844128 |
| Engelhart K et al. | In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models. | 2005 | Arch. Dermatol. Res. | pmid:15952007 |
| Hultsch T et al. | Ascomycin macrolactam derivative SDZ ASM 981 inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner. | 1998 | Arch. Dermatol. Res. | pmid:9808344 |
| Lauerma AI et al. | Topical FK506: suppression of allergic and irritant contact dermatitis in the guinea pig. | 1994 | Arch. Dermatol. Res. | pmid:7526805 |
| Borro JM et al. | Long-term success of combined kidney-lung transplantation in a patient with cystic fibrosis. | 2013 | Arch. Bronconeumol. | pmid:23427867 |
| Reig Mezquida JP et al. | Thrombotic microangiopathy associated with tacrolimus in lung transplantation. | 2015 | Arch. Bronconeumol. | pmid:25138798 |
| Zurbano F et al. | Maternity and lung transplantation: cases in Spain. | 2012 | Arch. Bronconeumol. | pmid:22771003 |
| Wen H et al. | Characterization of the binding sites for the interactions between FKBP12 and intracellular calcium release channels. | 2012 | Arch. Biochem. Biophys. | pmid:22100703 |
| Vincent SH et al. | In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes: identification of a major metabolite and of cytochrome P450 3A as the major enzymes responsible for its metabolism. | 1992 | Arch. Biochem. Biophys. | pmid:1373595 |
| Yin M and Ochs RS | Mechanism for the paradoxical inhibition and stimulation of calcineurin by the immunosuppresive drug tacrolimus (FK506). | 2003 | Arch. Biochem. Biophys. | pmid:14592464 |
| Salowe SP and Hermes JD | Competitive and slow-binding inhibition of calcineurin by drug x immunophilin complexes. | 1998 | Arch. Biochem. Biophys. | pmid:9675023 |
| Tomono M et al. | Inhibitors of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts. | 1998 | Arch. Biochem. Biophys. | pmid:9606972 |
| Kakegawa T et al. | Rapamycin induces binding activity to the terminal oligopyrimidine tract of ribosomal protein mRNA in rats. | 2002 | Arch. Biochem. Biophys. | pmid:12051685 |
| Mukerjee N et al. | Caspase-mediated proteolytic activation of calcineurin in thapsigargin-mediated apoptosis in SH-SY5Y neuroblastoma cells. | 2000 | Arch. Biochem. Biophys. | pmid:10898953 |
| Fryer JP et al. | Bacterial translocation in a large-animal model of small-bowel transplantation. Portal vs systemic venous drainage and the effect of tacrolimus immunosuppression. | 1996 | Arch Surg | pmid:8546583 |
| Harmon JV et al. | Experimental short-term immunosuppression after bowel transplantation and donor-specific bone marrow infusion. | 2001 | Arch Surg | pmid:11448397 |
| Echigo Y et al. | Effects of cyclosporine and tacrolimus (FK 506) on acute pancreatitis in mice. | 1995 | Arch Surg | pmid:7528496 |
| Freise CE et al. | Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation. | 2003 | Arch Surg | pmid:14557130 |
| Johnson MW et al. | Hepatitis C viral infection in liver transplantation. | 1996 | Arch Surg | pmid:8611094 |
| Stötter H and Lotze MT | Human lymphokine-activated killer cell activity. Role of IL-2, IL-4, and IL-7. | 1991 | Arch Surg | pmid:1726819 |
| Sánchez Ferreiro AV and Muñoz Bellido L | [Tacrolimus in the treatment of atopic kerato-conjunctivitis]. | 2013 | Arch Soc Esp Oftalmol | pmid:23886369 |
| RodrÃguez-AusÃn P et al. | Topical tacrolimus 0.03% for the treatment of ocular psoriasis. | 2016 | Arch Soc Esp Oftalmol | pmid:27130870 |
| Rybojad M | [Atopic dermatitis]. | 2012 | Arch Pediatr | pmid:22796288 |
| Monchaud C et al. | [Long lasting side effects of immunosuppressants in children]. | 2007 | Arch Pediatr | pmid:17442546 |
| Geramizadeh B et al. | Post-transplantation lymphoproliferative disorder after liver transplantation: report of 5 cases among more than 550 liver transplants in Iran. | 2010 | Arch Iran Med | pmid:20804309 |
| Dehghani SM et al. | Tacrolimus related hypertrophic cardiomyopathy in liver transplant recipients. | 2010 | Arch Iran Med | pmid:20187665 |
| Yeh C et al. | Effect of FK506 on functional recovery after facial nerve injury in the rat. | 2007 Sep-Oct | Arch Facial Plast Surg | pmid:17875826 |
| Kreuter A et al. | 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study. | 2006 | Arch Dermatol | pmid:16983001 |
| Stern RS | Topical calcineurin inhibitors labeling: putting the "box" in perspective. | 2006 | Arch Dermatol | pmid:16983018 |
| Travis LB et al. | Successful treatment of vitiligo with 0.1% tacrolimus ointment. | 2003 | Arch Dermatol | pmid:12756092 |
| Lepe V et al. | A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. | 2003 | Arch Dermatol | pmid:12756094 |
| Plettenberg H et al. | Childhood vitiligo and tacrolimus: immunomodulating treatment for an autoimmune disease. | 2003 | Arch Dermatol | pmid:12756103 |
| Lübbe J et al. | Adults with atopic dermatitis and herpes simplex and topical therapy with tacrolimus: what kind of prevention? | 2003 | Arch Dermatol | pmid:12756112 |
| Bakos L and Bakos RM | Focal acne during topical tacrolimus therapy for vitiligo. | 2007 | Arch Dermatol | pmid:17875902 |
| Laffitte E et al. | Erosive pustular dermatosis of the scalp: treatment with topical tacrolimus. | 2003 | Arch Dermatol | pmid:12810500 |
| Chu J et al. | Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid. | 2003 | Arch Dermatol | pmid:12810523 |
| Allen A et al. | Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. | 2001 | Arch Dermatol | pmid:11405764 |
| Eichenfield LF et al. | 1% pimecrolimus cream for atopic dermatitis. | 2003 | Arch Dermatol | pmid:14568846 |
| Thiers BH | Topical tacrolimus: treatment failure in a patient with alopecia areata. | 2000 | Arch Dermatol | pmid:10632221 |
| Rotunda AM et al. | Hyperkeratotic plaques on the palms and soles. Palmoplantar lichen planus, hyperkeratotic variant. | 2004 | Arch Dermatol | pmid:15492196 |
| Laffitte E and Panizzon RG | Is topical tacrolimus really an effective therapy for Hailey-Hailey disease? | 2004 | Arch Dermatol | pmid:15492199 |
| Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study. The European FK 506 Multicentre Psoriasis Study Group. | 1996 | Arch Dermatol | pmid:8629845 | |
| Firooz A et al. | Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial. | 2006 | Arch Dermatol | pmid:16924062 |
| Bigby M | A thorough systematic review of treatments for atopic eczema. | 2001 | Arch Dermatol | pmid:11735714 |
| Bernard LA et al. | A rosacea-like granulomatous eruption in a patient using tacrolimus ointment for atopic dermatitis. | 2003 | Arch Dermatol | pmid:12588240 |
| Zonneveld IM et al. | Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. | 1998 | Arch Dermatol | pmid:9762021 |
| Choi CJ and Nghiem P | Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients. | 2001 | Arch Dermatol | pmid:11559218 |
| Lener EV et al. | Successful treatment of erosive lichen planus with topical tacrolimus. | 2001 | Arch Dermatol | pmid:11295919 |
| Mehrabi D and Pandya AG | A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo. | 2006 | Arch Dermatol | pmid:16847214 |
| Colebunders R et al. | HIV eosinophilic folliculitis in Uganda. | 2006 | Arch Dermatol | pmid:16847219 |
| Lebwohl M et al. | Proven efficacy of tacrolimus for facial and intertriginous psoriasis. | 2005 | Arch Dermatol | pmid:16172314 |
| Neill SM and Lewis FM | Vulvovaginal lichen planus: a disease in need of a unified approach. | 2008 | Arch Dermatol | pmid:19015426 |
| Gorman CR and White SW | Rosaceiform dermatitis as a complication of treatment of facial seborrheic dermatitis with 1% pimecrolimus cream. | 2005 | Arch Dermatol | pmid:16172323 |
| Cooper SM et al. | Vulvovaginal lichen planus treatment: a survey of current practices. | 2008 | Arch Dermatol | pmid:19015433 |
| Heffernan MP et al. | 0.1% tacrolimus ointment in the treatment of discoid lupus erythematosus. | 2005 | Arch Dermatol | pmid:16172325 |
| Lally A et al. | Penile pyoderma gangrenosum treated with topical tacrolimus. | 2005 | Arch Dermatol | pmid:16172330 |
| Le Cleach L et al. | Is topical monotherapy effective for localized pyoderma gangrenosum? | 2011 | Arch Dermatol | pmid:21242400 |
| Pomerantz RG et al. | Posttransplant cutaneous T-cell lymphoma: case reports and review of the association of calcineurin inhibitor use with posttransplant lymphoproliferative disease risk. | 2010 | Arch Dermatol | pmid:20479299 |
| Sand C and Thomsen HK | Topical tacrolimus ointment is an effective therapy for Hailey-Hailey disease. | 2003 | Arch Dermatol | pmid:14623698 |
| Guenova E et al. | Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab. | 2011 | Arch Dermatol | pmid:21680759 |
| Singh MN et al. | Solitary cutaneous nodule in an immunocompromised patient. | 2007 | Arch Dermatol | pmid:18087016 |
| Ng W and Ikeda S | Mount Tsukuba and the origin of tacrolimus. | 2009 | Arch Dermatol | pmid:19289758 |
| Sardana K et al. | Effect of tacrolimus on vitiligo in absence of UV radiation exposure. | 2007 | Arch Dermatol | pmid:17224558 |
| Carroll CL et al. | Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment. | 2005 | Arch Dermatol | pmid:15655140 |
| Patel RR et al. | The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis. | 2003 | Arch Dermatol | pmid:12975161 |
| Nagao K et al. | A case of generalized pustular psoriasis treated with topical tacrolimus. | 2003 | Arch Dermatol | pmid:12975175 |
| Castelo-Soccio L et al. | Induced lentiginosis with use of topical calcineurin inhibitors. | 2012 | Arch Dermatol | pmid:22710469 |
| Ward KM et al. | Eyelash trichomegaly associated with systemic tacrolimus. | 2006 | Arch Dermatol | pmid:16490862 |
| Ostovari N et al. | Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure. | 2006 | Arch Dermatol | pmid:16490866 |
| Chapman MS et al. | 0.1% tacrolimus ointment for the treatment of intertrigo. | 2005 | Arch Dermatol | pmid:15967933 |
| Olivier V et al. | Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study. | 2002 | Arch Dermatol | pmid:12374539 |
| Toutous-Trellu L et al. | Topical tacrolimus for effective treatment of eosinophilic folliculitis associated with human immunodeficiency virus infection. | 2005 | Arch Dermatol | pmid:16230556 |
| Kunstfeld R et al. | Successful treatment of vulvar lichen sclerosus with topical tacrolimus. | 2003 | Arch Dermatol | pmid:12873877 |
| Reitamo S et al. | Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. | 2000 | Arch Dermatol | pmid:10926735 |
| Sugiura H et al. | Long-term efficacy of tacrolimus ointment for recalcitrant facial erythema resistant to topical corticosteroids in adult patients with atopic dermatitis. | 2000 | Arch Dermatol | pmid:10926750 |
| Byrd JA et al. | Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus. | 2004 | Arch Dermatol | pmid:15210463 |
| Shah KN and Yan AC | Low but detectable serum levels of tacrolimus seen with the use of very dilute, extemporaneously compounded formulations of tacrolimus ointment in the treatment of patients with netherton syndrome. | 2006 | Arch Dermatol | pmid:17043199 |
| Antille C et al. | Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. | 2004 | Arch Dermatol | pmid:15096374 |
| Banky JP et al. | Successful treatment of epidermolysis bullosa pruriginosa with topical tacrolimus. | 2004 | Arch Dermatol | pmid:15262686 |
| Passeron T et al. | Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood. | 2007 | Arch Dermatol | pmid:17438179 |
| Bruce A and Rogers RS | New and old therapeutics for oral ulcerations. | 2007 | Arch Dermatol | pmid:17438186 |
| Qureshi A and Fischer MA | Topical calcineurin inhibitors revisited. | 2007 | Arch Dermatol | pmid:17438195 |
| Rapaport MJ | Topical tacrolimus. | 2005 | Arch Dermatol | pmid:16301404 |
| Cheng A and Mann C | Oral erosive lichen planus treated with efalizumab. | 2006 | Arch Dermatol | pmid:16785369 |
| Mackelfresh J et al. | Combination therapy of doxycycline and topical tacrolimus for venous ulcers. | 2005 | Arch Dermatol | pmid:16301410 |
| Sniezek PJ et al. | Annular atrophic plaques on the arms of a 57-year-old woman. | 2006 | Arch Dermatol | pmid:16785386 |
| Hall VC et al. | Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment. | 2003 | Arch Dermatol | pmid:12925404 |